"Designing Growth Strategies is in our DNA"

Cancer Profiling Market Size, Share & Industry Analysis, By Product and Services (Instruments, Reagents and Consumables, and Services), By Technology (Immunoassays, Next-Generation Sequencing, Polymerase Chain Reaction, In-situ Hybridization, Microarrays, Mass Spectrometry, and Other Technologies), By Biomarker Type (Genetic Biomarkers, Protein Biomarkers, and Other Biomarkers), By Cancer Type (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, & Others), By Application (Diagnostics, Prognosis & Risk Assessment, & Others), By End-user, and Regional Forecast, 2026-2034

Last Updated: March 16, 2026 | Format: PDF | Report ID: FBI115419

 

We will customize the report to meet your research goals, helping you gain a competitive edge, and make informed decisions.

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Trends
  4. Key Insights
    1. Advancements in Cancer Profiling
    2. New Product Launchers
    3. Key Industry Developments - (Mergers, Acquisitions & Partnerships, etc.)
  5. Global Cancer Profiling Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Product and Services
      1. Instruments
      2. Reagents and Consumables
      3. Services
    2. Market Analysis, Insights and Forecast – By Technology
      1. Immunoassays
      2. Next-Generation Sequencing (NGS)
      3. Polymerase Chain Reaction (PCR)
      4. In-situ Hybridization (ISH)
      5. Microarrays
      6. Mass Spectrometry
      7. Other Technologies
    3. Market Analysis, Insights and Forecast – By Biomarker Type
      1. Genetic Biomarkers
      2. Protein Biomarkers
      3. Other Biomarkers
    4. Market Analysis, Insights and Forecast – By Cancer Type
      1. Breast Cancer
      2. Lung Cancer
      3. Colorectal Cancer
      4. Prostate Cancer
      5. Melanoma
      6. Other Cancer Types
    5. Market Analysis, Insights and Forecast – By Application
      1. Diagnostics
      2. Prognosis & Risk Assessment
      3. Treatment Selection & Monitoring
      4. Research Applications
      5. Screening & Early Detection
    6. Market Analysis, Insights and Forecast – By End-user
      1. Hospitals & Reference Laboratories
      2. Academic & Research Institutes
      3. Pharmaceutical & Biotechnology Companies
      4. Contract Research Organizations
    7. Market Analysis, Insights and Forecast – By Region
      1. North America
      2. Europe
      3. Asia Pacific
      4. Latin America
      5. Middle East & Africa
  6. North America Cancer Profiling Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Product and Services
      1. Instruments
      2. Reagents and Consumables
      3. Services
    2. Market Analysis, Insights and Forecast – By Technology
      1. Immunoassays
      2. Next-Generation Sequencing (NGS)
      3. Polymerase Chain Reaction (PCR)
      4. In-situ Hybridization (ISH)
      5. Microarrays
      6. Mass Spectrometry
      7. Other Technologies
    3. Market Analysis, Insights and Forecast – By Biomarker Type
      1. Genetic Biomarkers
      2. Protein Biomarkers
      3. Other Biomarkers
    4. Market Analysis, Insights and Forecast – By Cancer Type
      1. Breast Cancer
      2. Lung Cancer
      3. Colorectal Cancer
      4. Prostate Cancer
      5. Melanoma
      6. Other Cancer Types
    5. Market Analysis, Insights and Forecast – By Application
      1. Diagnostics
      2. Prognosis & Risk Assessment
      3. Treatment Selection & Monitoring
      4. Research Applications
      5. Screening & Early Detection
    6. Market Analysis, Insights and Forecast – By End-user
      1. Hospitals & Reference Laboratories
      2. Academic & Research Institutes
      3. Pharmaceutical & Biotechnology Companies
      4. Contract Research Organizations
    7. Market Analysis, Insights and Forecast – By Country
      1. U.S.
        1. By Cancer Type
      2. Canada
        1. By Cancer Type
  7. Europe Cancer Profiling Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Product and Services
      1. Instruments
      2. Reagents and Consumables
      3. Services
    2. Market Analysis, Insights and Forecast – By Technology
      1. Immunoassays
      2. Next-Generation Sequencing (NGS)
      3. Polymerase Chain Reaction (PCR)
      4. In-situ Hybridization (ISH)
      5. Microarrays
      6. Mass Spectrometry
      7. Other Technologies
    3. Market Analysis, Insights and Forecast – By Biomarker Type
      1. Genetic Biomarkers
      2. Protein Biomarkers
      3. Other Biomarkers
    4. Market Analysis, Insights and Forecast – By Cancer Type
      1. Breast Cancer
      2. Lung Cancer
      3. Colorectal Cancer
      4. Prostate Cancer
      5. Melanoma
      6. Other Cancer Types
    5. Market Analysis, Insights and Forecast – By Application
      1. Diagnostics
      2. Prognosis & Risk Assessment
      3. Treatment Selection & Monitoring
      4. Research Applications
      5. Screening & Early Detection
    6. Market Analysis, Insights and Forecast – By End-user
      1. Hospitals & Reference Laboratories
      2. Academic & Research Institutes
      3. Pharmaceutical & Biotechnology Companies
      4. Contract Research Organizations
    7. Market Analysis, Insights and Forecast – By County/ Sub-region
      1. Germany
        1. By Cancer Type
      2. U.K.
        1. By Cancer Type
      3. France
        1. By Cancer Type
      4. Italy
        1. By Cancer Type
      5. Spain
        1. By Cancer Type
      6. Scandinavia
        1. By Cancer Type
      7. Rest of Europe
        1. By Cancer Type
  8. Asia Pacific Cancer Profiling Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Product and Services
      1. Instruments
      2. Reagents and Consumables
      3. Services
    2. Market Analysis, Insights and Forecast – By Technology
      1. Immunoassays
      2. Next-Generation Sequencing (NGS)
      3. Polymerase Chain Reaction (PCR)
      4. In-situ Hybridization (ISH)
      5. Microarrays
      6. Mass Spectrometry
      7. Other Technologies
    3. Market Analysis, Insights and Forecast – By Biomarker Type
      1. Genetic Biomarkers
      2. Protein Biomarkers
      3. Other Biomarkers
    4. Market Analysis, Insights and Forecast – By Cancer Type
      1. Breast Cancer
      2. Lung Cancer
      3. Colorectal Cancer
      4. Prostate Cancer
      5. Melanoma
      6. Other Cancer Types
    5. Market Analysis, Insights and Forecast – By Application
      1. Diagnostics
      2. Prognosis & Risk Assessment
      3. Treatment Selection & Monitoring
      4. Research Applications
      5. Screening & Early Detection
    6. Market Analysis, Insights and Forecast – By End-user
      1. Hospitals & Reference Laboratories
      2. Academic & Research Institutes
      3. Pharmaceutical & Biotechnology Companies
      4. Contract Research Organizations
    7. Market Analysis, Insights and Forecast – By Country/ Sub-region
      1. China
        1. By Cancer Type
      2. India
        1. By Cancer Type
      3. Japan
        1. By Cancer Type
      4. Australia
        1. By Cancer Type
      5. Southeast Asia
        1. By Cancer Type
      6. Rest of Asia Pacific
        1. By Cancer Type
  9. Latin America Cancer Profiling Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Product and Services
      1. Instruments
      2. Reagents and Consumables
      3. Services
    2. Market Analysis, Insights and Forecast – By Technology
      1. Immunoassays
      2. Next-Generation Sequencing (NGS)
      3. Polymerase Chain Reaction (PCR)
      4. In-situ Hybridization (ISH)
      5. Microarrays
      6. Mass Spectrometry
      7. Other Technologies
    3. Market Analysis, Insights and Forecast – By Biomarker Type
      1. Genetic Biomarkers
      2. Protein Biomarkers
      3. Other Biomarkers
    4. Market Analysis, Insights and Forecast – By Cancer Type
      1. Breast Cancer
      2. Lung Cancer
      3. Colorectal Cancer
      4. Prostate Cancer
      5. Melanoma
      6. Other Cancer Types
    5. Market Analysis, Insights and Forecast – By Application
      1. Diagnostics
      2. Prognosis & Risk Assessment
      3. Treatment Selection & Monitoring
      4. Research Applications
      5. Screening & Early Detection
    6. Market Analysis, Insights and Forecast – By End-user
      1. Hospitals & Reference Laboratories
      2. Academic & Research Institutes
      3. Pharmaceutical & Biotechnology Companies
      4. Contract Research Organizations
    7. Market Analysis, Insights and Forecast – By Country/ Sub-region
      1. Brazil
        1. By Cancer Type
      2. Mexico
        1. By Cancer Type
      3. Rest of Latin America
        1. By Cancer Type
  10. Middle East & Africa Cancer Profiling Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Product and Services
      1. Instruments
      2. Reagents and Consumables
      3. Services
    2. Market Analysis, Insights and Forecast – By Technology
      1. Immunoassays
      2. Next-Generation Sequencing (NGS)
      3. Polymerase Chain Reaction (PCR)
      4. In-situ Hybridization (ISH)
      5. Microarrays
      6. Mass Spectrometry
      7. Other Technologies
    3. Market Analysis, Insights and Forecast – By Biomarker Type
      1. Genetic Biomarkers
      2. Protein Biomarkers
      3. Other Biomarkers
    4. Market Analysis, Insights and Forecast – By Cancer Type
      1. Breast Cancer
      2. Lung Cancer
      3. Colorectal Cancer
      4. Prostate Cancer
      5. Melanoma
      6. Other Cancer Types
    5. Market Analysis, Insights and Forecast – By Application
      1. Diagnostics
      2. Prognosis & Risk Assessment
      3. Treatment Selection & Monitoring
      4. Research Applications
      5. Screening & Early Detection
    6. Market Analysis, Insights and Forecast – By End-user
      1. Hospitals & Reference Laboratories
      2. Academic & Research Institutes
      3. Pharmaceutical & Biotechnology Companies
      4. Contract Research Organizations
    7. Market Analysis, Insights and Forecast – By Country/ Sub-region
      1. South Africa
        1. By Cancer Type
      2. GCC
        1. By Cancer Type
      3. Rest of Middle East & Africa
        1. By Cancer Type
  11. Competitive Analysis
    1. Global Market Share Analysis (2025)
    2. Company Profiles (Overview, Products, SWOT Analysis, Recent Developments, Strategies, Financials (Based on Availability))
      1. Tempus AI
      2. Natera, Inc.
      3. Guardant Health, Inc.
      4. Caris Life Sciences
      5. NeoGenomics Laboratories
      6. Exact Sciences Corporation
      7. F. Hoffmann-La Roche Ltd
      8. Labcorp
      9. Thermo Fisher Scientific Inc.
      10. Illumina, Inc.
  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Trends
  4. Key Insights
    1. Advancements in Cancer Profiling
    2. New Product Launchers
    3. Key Industry Developments - (Mergers, Acquisitions & Partnerships, etc.)
  5. Global Cancer Profiling Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Product and Services
      1. Instruments
      2. Reagents and Consumables
      3. Services
    2. Market Analysis, Insights and Forecast – By Technology
      1. Immunoassays
      2. Next-Generation Sequencing (NGS)
      3. Polymerase Chain Reaction (PCR)
      4. In-situ Hybridization (ISH)
      5. Microarrays
      6. Mass Spectrometry
      7. Other Technologies
    3. Market Analysis, Insights and Forecast – By Biomarker Type
      1. Genetic Biomarkers
      2. Protein Biomarkers
      3. Other Biomarkers
    4. Market Analysis, Insights and Forecast – By Cancer Type
      1. Breast Cancer
      2. Lung Cancer
      3. Colorectal Cancer
      4. Prostate Cancer
      5. Melanoma
      6. Other Cancer Types
    5. Market Analysis, Insights and Forecast – By Application
      1. Diagnostics
      2. Prognosis & Risk Assessment
      3. Treatment Selection & Monitoring
      4. Research Applications
      5. Screening & Early Detection
    6. Market Analysis, Insights and Forecast – By End-user
      1. Hospitals & Reference Laboratories
      2. Academic & Research Institutes
      3. Pharmaceutical & Biotechnology Companies
      4. Contract Research Organizations
    7. Market Analysis, Insights and Forecast – By Region
      1. North America
      2. Europe
      3. Asia Pacific
      4. Latin America
      5. Middle East & Africa
  6. North America Cancer Profiling Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Product and Services
      1. Instruments
      2. Reagents and Consumables
      3. Services
    2. Market Analysis, Insights and Forecast – By Technology
      1. Immunoassays
      2. Next-Generation Sequencing (NGS)
      3. Polymerase Chain Reaction (PCR)
      4. In-situ Hybridization (ISH)
      5. Microarrays
      6. Mass Spectrometry
      7. Other Technologies
    3. Market Analysis, Insights and Forecast – By Biomarker Type
      1. Genetic Biomarkers
      2. Protein Biomarkers
      3. Other Biomarkers
    4. Market Analysis, Insights and Forecast – By Cancer Type
      1. Breast Cancer
      2. Lung Cancer
      3. Colorectal Cancer
      4. Prostate Cancer
      5. Melanoma
      6. Other Cancer Types
    5. Market Analysis, Insights and Forecast – By Application
      1. Diagnostics
      2. Prognosis & Risk Assessment
      3. Treatment Selection & Monitoring
      4. Research Applications
      5. Screening & Early Detection
    6. Market Analysis, Insights and Forecast – By End-user
      1. Hospitals & Reference Laboratories
      2. Academic & Research Institutes
      3. Pharmaceutical & Biotechnology Companies
      4. Contract Research Organizations
    7. Market Analysis, Insights and Forecast – By Country
      1. U.S.
        1. By Cancer Type
      2. Canada
        1. By Cancer Type
  7. Europe Cancer Profiling Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Product and Services
      1. Instruments
      2. Reagents and Consumables
      3. Services
    2. Market Analysis, Insights and Forecast – By Technology
      1. Immunoassays
      2. Next-Generation Sequencing (NGS)
      3. Polymerase Chain Reaction (PCR)
      4. In-situ Hybridization (ISH)
      5. Microarrays
      6. Mass Spectrometry
      7. Other Technologies
    3. Market Analysis, Insights and Forecast – By Biomarker Type
      1. Genetic Biomarkers
      2. Protein Biomarkers
      3. Other Biomarkers
    4. Market Analysis, Insights and Forecast – By Cancer Type
      1. Breast Cancer
      2. Lung Cancer
      3. Colorectal Cancer
      4. Prostate Cancer
      5. Melanoma
      6. Other Cancer Types
    5. Market Analysis, Insights and Forecast – By Application
      1. Diagnostics
      2. Prognosis & Risk Assessment
      3. Treatment Selection & Monitoring
      4. Research Applications
      5. Screening & Early Detection
    6. Market Analysis, Insights and Forecast – By End-user
      1. Hospitals & Reference Laboratories
      2. Academic & Research Institutes
      3. Pharmaceutical & Biotechnology Companies
      4. Contract Research Organizations
    7. Market Analysis, Insights and Forecast – By County/ Sub-region
      1. Germany
        1. By Cancer Type
      2. U.K.
        1. By Cancer Type
      3. France
        1. By Cancer Type
      4. Italy
        1. By Cancer Type
      5. Spain
        1. By Cancer Type
      6. Scandinavia
        1. By Cancer Type
      7. Rest of Europe
        1. By Cancer Type
  8. Asia Pacific Cancer Profiling Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Product and Services
      1. Instruments
      2. Reagents and Consumables
      3. Services
    2. Market Analysis, Insights and Forecast – By Technology
      1. Immunoassays
      2. Next-Generation Sequencing (NGS)
      3. Polymerase Chain Reaction (PCR)
      4. In-situ Hybridization (ISH)
      5. Microarrays
      6. Mass Spectrometry
      7. Other Technologies
    3. Market Analysis, Insights and Forecast – By Biomarker Type
      1. Genetic Biomarkers
      2. Protein Biomarkers
      3. Other Biomarkers
    4. Market Analysis, Insights and Forecast – By Cancer Type
      1. Breast Cancer
      2. Lung Cancer
      3. Colorectal Cancer
      4. Prostate Cancer
      5. Melanoma
      6. Other Cancer Types
    5. Market Analysis, Insights and Forecast – By Application
      1. Diagnostics
      2. Prognosis & Risk Assessment
      3. Treatment Selection & Monitoring
      4. Research Applications
      5. Screening & Early Detection
    6. Market Analysis, Insights and Forecast – By End-user
      1. Hospitals & Reference Laboratories
      2. Academic & Research Institutes
      3. Pharmaceutical & Biotechnology Companies
      4. Contract Research Organizations
    7. Market Analysis, Insights and Forecast – By Country/ Sub-region
      1. China
        1. By Cancer Type
      2. India
        1. By Cancer Type
      3. Japan
        1. By Cancer Type
      4. Australia
        1. By Cancer Type
      5. Southeast Asia
        1. By Cancer Type
      6. Rest of Asia Pacific
        1. By Cancer Type
  9. Latin America Cancer Profiling Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Product and Services
      1. Instruments
      2. Reagents and Consumables
      3. Services
    2. Market Analysis, Insights and Forecast – By Technology
      1. Immunoassays
      2. Next-Generation Sequencing (NGS)
      3. Polymerase Chain Reaction (PCR)
      4. In-situ Hybridization (ISH)
      5. Microarrays
      6. Mass Spectrometry
      7. Other Technologies
    3. Market Analysis, Insights and Forecast – By Biomarker Type
      1. Genetic Biomarkers
      2. Protein Biomarkers
      3. Other Biomarkers
    4. Market Analysis, Insights and Forecast – By Cancer Type
      1. Breast Cancer
      2. Lung Cancer
      3. Colorectal Cancer
      4. Prostate Cancer
      5. Melanoma
      6. Other Cancer Types
    5. Market Analysis, Insights and Forecast – By Application
      1. Diagnostics
      2. Prognosis & Risk Assessment
      3. Treatment Selection & Monitoring
      4. Research Applications
      5. Screening & Early Detection
    6. Market Analysis, Insights and Forecast – By End-user
      1. Hospitals & Reference Laboratories
      2. Academic & Research Institutes
      3. Pharmaceutical & Biotechnology Companies
      4. Contract Research Organizations
    7. Market Analysis, Insights and Forecast – By Country/ Sub-region
      1. Brazil
        1. By Cancer Type
      2. Mexico
        1. By Cancer Type
      3. Rest of Latin America
        1. By Cancer Type
  10. Middle East & Africa Cancer Profiling Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Product and Services
      1. Instruments
      2. Reagents and Consumables
      3. Services
    2. Market Analysis, Insights and Forecast – By Technology
      1. Immunoassays
      2. Next-Generation Sequencing (NGS)
      3. Polymerase Chain Reaction (PCR)
      4. In-situ Hybridization (ISH)
      5. Microarrays
      6. Mass Spectrometry
      7. Other Technologies
    3. Market Analysis, Insights and Forecast – By Biomarker Type
      1. Genetic Biomarkers
      2. Protein Biomarkers
      3. Other Biomarkers
    4. Market Analysis, Insights and Forecast – By Cancer Type
      1. Breast Cancer
      2. Lung Cancer
      3. Colorectal Cancer
      4. Prostate Cancer
      5. Melanoma
      6. Other Cancer Types
    5. Market Analysis, Insights and Forecast – By Application
      1. Diagnostics
      2. Prognosis & Risk Assessment
      3. Treatment Selection & Monitoring
      4. Research Applications
      5. Screening & Early Detection
    6. Market Analysis, Insights and Forecast – By End-user
      1. Hospitals & Reference Laboratories
      2. Academic & Research Institutes
      3. Pharmaceutical & Biotechnology Companies
      4. Contract Research Organizations
    7. Market Analysis, Insights and Forecast – By Country/ Sub-region
      1. South Africa
        1. By Cancer Type
      2. GCC
        1. By Cancer Type
      3. Rest of Middle East & Africa
        1. By Cancer Type
  11. Competitive Analysis
    1. Global Market Share Analysis (2025)
    2. Company Profiles (Overview, Products, SWOT Analysis, Recent Developments, Strategies, Financials (Based on Availability))
      1. Tempus AI
      2. Natera, Inc.
      3. Guardant Health, Inc.
      4. Caris Life Sciences
      5. NeoGenomics Laboratories
      6. Exact Sciences Corporation
      7. F. Hoffmann-La Roche Ltd
      8. Labcorp
      9. Thermo Fisher Scientific Inc.
      10. Illumina, Inc.
Read Less

Figure 1:  Global Cancer Profiling Market Revenue Breakdown (USD billion, %) by Region, 2025 & 2034

Figure 2:  Global Cancer Profiling Market Value Share (%), by Product and Services, 2025 & 2034

Figure 3:  Global Cancer Profiling Market Value Share (%), by Technology, 2025 & 2034

Figure 4:  Global Cancer Profiling Market Value Share (%), by Biomarker Type, 2025 & 2034

Figure 5:  Global Cancer Profiling Market Value Share (%), by CancerType, 2025 & 2034

Figure 6:  Global Cancer Profiling Market Value Share (%), by Application, 2025 & 2034

Figure 7:  Global Cancer Profiling Market Value Share (%), by End-user, 2025 & 2034

Figure 8:  Global Cancer Profiling Market Value (USD billion), by Region, 2025 & 2034

Figure 9:  North America Cancer Profiling Market Value (USD billion), by Product and Services, 2025 & 2034

Figure 10:  North America Cancer Profiling Market Value Share (%), by Product and Services, 2025

Figure 11:  North America Cancer Profiling Market Value (USD billion), by Technology, 2025 & 2034

Figure 12:  North America Cancer Profiling Market Value Share (%), by Technology, 2025

Figure 13:  North America Cancer Profiling Market Value (USD billion), by Biomarker Type, 2025 & 2034

Figure 14:  North America Cancer Profiling Market Value Share (%), by Biomarker Type, 2025

Figure 15:  North America Cancer Profiling Market Value (USD billion), by Cancer Type, 2025 & 2034

Figure 16:  North America Cancer Profiling Market Value Share (%), by Cancer Type, 2025

Figure 17:  North America Cancer Profiling Market Value (USD billion), by Application, 2025 & 2034

Figure 18:  North America Cancer Profiling Market Value Share (%), by Application, 2025

Figure 19:  North America Cancer Profiling Market Value (USD billion), by End-user, 2025 & 2034

Figure 20:  North America Cancer Profiling Market Value Share (%), by End-user, 2025

Figure 21:  North America Cancer Profiling Market Value (USD billion), By Country, 2025 & 2034

Figure 22:  North America Cancer Profiling Market Value Share (%), By Country, 2025

Figure 23:  Europe Cancer Profiling Market Value (USD billion), by Product and Services, 2025 & 2034

Figure 24:  Europe Cancer Profiling Market Value Share (%), by Product and Services, 2025

Figure 25:  Europe Cancer Profiling Market Value (USD billion), by Technology, 2025 & 2034

Figure 26:  Europe Cancer Profiling Market Value Share (%), by Technology, 2025

Figure 27:  Europe Cancer Profiling Market Value (USD billion), by Biomarker Type, 2025 & 2034

Figure 28:  Europe Cancer Profiling Market Value Share (%), by Biomarker Type, 2025

Figure 29:  Europe Cancer Profiling Market Value (USD billion), by Cancer Type, 2025 & 2034

Figure 30:  Europe Cancer Profiling Market Value Share (%), by Cancer Type, 2025

Figure 31:  Europe Cancer Profiling Market Value (USD billion), by Application, 2025 & 2034

Figure 32:  Europe Cancer Profiling Market Value Share (%), by Application, 2025

Figure 33:  Europe Cancer Profiling Market Value (USD billion), by End-user, 2025 & 2034

Figure 34:  Europe Cancer Profiling Market Value Share (%), by End-user, 2025

Figure 35:  Europe Cancer Profiling Market Value (USD billion), By Country/ Sub-region, 2025 & 2034

Figure 36:  Europe Cancer Profiling Market Value Share (%), By Country/ Sub-region, 2025

Figure 37:  Asia Pacific Cancer Profiling Market Value (USD billion), by Product and Services, 2025 & 2034

Figure 38:  Asia Pacific Cancer Profiling Market Value Share (%), by Product and Services, 2025

Figure 39:  Asia Pacific Cancer Profiling Market Value (USD billion), by Technology, 2025 & 2034

Figure 40:  Asia Pacific Cancer Profiling Market Value Share (%), by Technology, 2025

Figure 41:  Asia Pacific Cancer Profiling Market Value (USD billion), by Biomarker Type, 2025 & 2034

Figure 42:  Asia Pacific Cancer Profiling Market Value Share (%), by Biomarker Type, 2025

Figure 43:  Asia Pacific Cancer Profiling Market Value (USD billion), by Cancer Type, 2025 & 2034

Figure 44:  Asia Pacific Cancer Profiling Market Value Share (%), by Cancer Type, 2025

Figure 45:  Asia Pacific Cancer Profiling Market Value (USD billion), by Application, 2025 & 2034

Figure 46:  Asia Pacific Cancer Profiling Market Value Share (%), by Application, 2025

Figure 47:  Asia Pacific Cancer Profiling Market Value (USD billion), by End-user, 2025 & 2034

Figure 48:  Asia Pacific Cancer Profiling Market Value Share (%), by End-user, 2025

Figure 49:  Asia Pacific Cancer Profiling Market Value (USD billion), By Country/ Sub-region, 2025 & 2034

Figure 50:  Asia Pacific Cancer Profiling Market Value Share (%), By Country/ Sub-region, 2025

Figure 51:  Latin America Cancer Profiling Market Value (USD billion), by Product and Services, 2025 & 2034

Figure 52:  Latin America Cancer Profiling Market Value Share (%), by Product and Services, 2025

Figure 53:  Latin America Cancer Profiling Market Value (USD billion), by Technology, 2025 & 2034

Figure 54:  Latin America Cancer Profiling Market Value Share (%), by Technology, 2025

Figure 55:  Latin America Cancer Profiling Market Value (USD billion), by Biomarker Type, 2025 & 2034

Figure 56:  Latin America Cancer Profiling Market Value Share (%), by Biomarker Type, 2025

Figure 57:  Latin America Cancer Profiling Market Value (USD billion), by Cancer Type, 2025 & 2034

Figure 58:  Latin America Cancer Profiling Market Value Share (%), by Cancer Type, 2025

Figure 59:  Latin America Cancer Profiling Market Value (USD billion), by Application, 2025 & 2034

Figure 60:  Latin America Cancer Profiling Market Value Share (%), by Application, 2025

Figure 61:  Latin America Cancer Profiling Market Value (USD billion), by End-user, 2025 & 2034

Figure 62:  Latin America Cancer Profiling Market Value Share (%), by End-user, 2025

Figure 63:  Latin America Cancer Profiling Market Value (USD billion), By Country/ Sub-region, 2025 & 2034

Figure 64:  Latin America Cancer Profiling Market Value Share (%), By Country/ Sub-region, 2025

Figure 65:  Middle East & Africa Cancer Profiling Market Value (USD billion), by Product and Services, 2025 & 2034

Figure 66:  Middle East & Africa Cancer Profiling Market Value Share (%), by Product and Services, 2025

Figure 67:  Middle East & Africa Cancer Profiling Market Value (USD billion), by Technology, 2025 & 2034

Figure 68:  Middle East & Africa Cancer Profiling Market Value Share (%), by Technology, 2025

Figure 69:  Middle East & Africa Cancer Profiling Market Value (USD billion), by Biomarker Type, 2025 & 2034

Figure 70:  Middle East & Africa Cancer Profiling Market Value Share (%), by Biomarker Type, 2025

Figure 71:  Middle East & Africa Cancer Profiling Market Value (USD billion), by Cancer Type, 2025 & 2034

Figure 72:  Middle East & Africa Cancer Profiling Market Value Share (%), by Cancer Type, 2025

Figure 73:  Middle East & Africa Cancer Profiling Market Value (USD billion), by Application, 2025 & 2034

Figure 74:  Middle East & Africa Cancer Profiling Market Value Share (%), by Application, 2025

Figure 75:  Middle East & Africa Cancer Profiling Market Value (USD billion), by End-user, 2025 & 2034

Figure 76:  Middle East & Africa Cancer Profiling Market Value Share (%), by End-user, 2025

Figure 77:  Middle East & Africa Cancer Profiling Market Value (USD billion), By Country/ Sub-region, 2025 & 2034

Figure 78:  Middle East & Africa Cancer Profiling Market Value Share (%), By Country/ Sub-region, 2025

Figure 79:  Global Cancer Profiling Market Share (%), By Company, 2025

Table 1:  Global Cancer Profiling Market Revenue (USD billion) Forecast, by Product and Services, 2021-2034

Table 2:  Global Cancer Profiling Market Revenue (USD billion) Forecast, by Technology, 2021-2034

Table 3:  Global Cancer Profiling Market Revenue (USD billion) Forecast, by Biomarker Type, 2021-2034

Table 4:  Global Cancer Profiling Market Revenue (USD billion) Forecast, by Cancer Type, 2021-2034

Table 5:  Global Cancer Profiling Market Revenue (USD billion) Forecast, by Application, 2021-2034

Table 6:  Global Cancer Profiling Market Revenue (USD billion) Forecast, by End-user, 2021-2034

Table 7:  Global Cancer Profiling Market Revenue (USD billion) Forecast, by Region, 2021-2034

Table 8:  North America Cancer Profiling Market Revenue (USD billion) Forecast, by Product and Services, 2021-2034

Table 9:  North America Cancer Profiling Market Revenue (USD billion) Forecast, by Technology, 2021-2034

Table 10:  North America Cancer Profiling Market Revenue (USD billion) Forecast, by Biomarker Type, 2021-2034

Table 11:  North America Cancer Profiling Market Revenue (USD billion) Forecast, by Cancer Type, 2021-2034

Table 12:  North America Cancer Profiling Market Revenue (USD billion) Forecast, by Application, 2021-2034

Table 13:  North America Cancer Profiling Market Revenue (USD billion) Forecast, by End-user, 2021-2034

Table 14:  North America Cancer Profiling Market Revenue (USD billion) Forecast, By Country, 2021-2034

Table 15:  U.S. Cancer Profiling Market Revenue (USD billion) Forecast, by Cancer Type, 2021-2034

Table 16:  Canada Cancer Profiling Market Revenue (USD billion) Forecast, by Cancer Type, 2021-2034

Table 17:  Europe Cancer Profiling Market Revenue (USD billion) Forecast, by Product and Services, 2021-2034

Table 18:  Europe Cancer Profiling Market Revenue (USD billion) Forecast, by Technology, 2021-2034

Table 19:  Europe Cancer Profiling Market Revenue (USD billion) Forecast, by Biomarker Type, 2021-2034

Table 20:  Europe Cancer Profiling Market Revenue (USD billion) Forecast, by Cancer Type, 2021-2034

Table 21:  Europe Cancer Profiling Market Revenue (USD billion) Forecast, by Application, 2021-2034

Table 22:  Europe Cancer Profiling Market Revenue (USD billion) Forecast, by End-user, 2021-2034

Table 23:  Europe Cancer Profiling Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034

Table 24:  U.K. Cancer Profiling Market Revenue (USD billion) Forecast, by Cancer Type, 2021-2034

Table 25:  Germany Cancer Profiling Market Revenue (USD billion) Forecast, by Cancer Type, 2021-2034

Table 26:  France Cancer Profiling Market Revenue (USD billion) Forecast, by Cancer Type, 2021-2034

Table 27:  Spain Cancer Profiling Market Revenue (USD billion) Forecast, by Cancer Type, 2021-2034

Table 28:  Italy Cancer Profiling Market Revenue (USD billion) Forecast, by Cancer Type, 2021-2034

Table 29:  Scandinavia Cancer Profiling Market Revenue (USD billion) Forecast, by Cancer Type, 2021-2034

Table 30:  Rest of Europe Cancer Profiling Market Revenue (USD billion) Forecast, by Cancer Type, 2021-2034

Table 31:  Asia Pacific Cancer Profiling Market Revenue (USD billion) Forecast, by Product and Services, 2021-2034

Table 32:  Asia Pacific Cancer Profiling Market Revenue (USD billion) Forecast, by Technology, 2021-2034

Table 33:  Asia Pacific Cancer Profiling Market Revenue (USD billion) Forecast, by Biomarker Type, 2021-2034

Table 34:  Asia Pacific Cancer Profiling Market Revenue (USD billion) Forecast, by Cancer Type, 2021-2034

Table 35:  Asia Pacific Cancer Profiling Market Revenue (USD billion) Forecast, by Application, 2021-2034

Table 36:  Asia Pacific Cancer Profiling Market Revenue (USD billion) Forecast, by End-user, 2021-2034

Table 37:  Asia Pacific Cancer Profiling Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034

Table 38:  Japan Cancer Profiling Market Revenue (USD billion) Forecast, by Cancer Type, 2021-2034

Table 39:  China Cancer Profiling Market Revenue (USD billion) Forecast, by Cancer Type, 2021-2034

Table 40:  India Cancer Profiling Market Revenue (USD billion) Forecast, by Cancer Type, 2021-2034

Table 41:  Australia Cancer Profiling Market Revenue (USD billion) Forecast, by Cancer Type, 2021-2034

Table 42:  Southeast Asia Cancer Profiling Market Revenue (USD billion) Forecast, by Cancer Type, 2021-2034

Table 43:  Rest of Asia Pacific Cancer Profiling Market Revenue (USD billion) Forecast, by Cancer Type, 2021-2034

Table 44:  Latin America Cancer Profiling Market Revenue (USD billion) Forecast, by Product and Services, 2021-2034

Table 45:  Latin America Cancer Profiling Market Revenue (USD billion) Forecast, by Technology, 2021-2034

Table 46:  Latin America Cancer Profiling Market Revenue (USD billion) Forecast, by Biomarker Type, 2021-2034

Table 47:  Latin America Cancer Profiling Market Revenue (USD billion) Forecast, by Cancer Type, 2021-2034

Table 48:  Latin America Cancer Profiling Market Revenue (USD billion) Forecast, by Application, 2021-2034

Table 49:  Latin America Cancer Profiling Market Revenue (USD billion) Forecast, by End-user, 2021-2034

Table 50:  Latin America Cancer Profiling Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034

Table 51:  Brazil Cancer Profiling Market Revenue (USD billion) Forecast, by Cancer Type, 2021-2034

Table 52:  Mexico Cancer Profiling Market Revenue (USD billion) Forecast, by Cancer Type, 2021-2034

Table 53:  Rest of Latin America Cancer Profiling Market Revenue (USD billion) Forecast, by Cancer Type, 2021-2034

Table 54:  Middle East & Africa Cancer Profiling Market Revenue (USD billion) Forecast, by Product and Services, 2021-2034

Table 55:  Middle East & Africa Cancer Profiling Market Revenue (USD billion) Forecast, by Technology, 2021-2034

Table 56:  Middle East & Africa Cancer Profiling Market Revenue (USD billion) Forecast, by Biomarker Type, 2021-2034

Table 57:  Middle East & Africa Cancer Profiling Market Revenue (USD billion) Forecast, by Cancer Type, 2021-2034

Table 58:  Middle East & Africa Cancer Profiling Market Revenue (USD billion) Forecast, by Application, 2021-2034

Table 59:  Middle East & Africa Cancer Profiling Market Revenue (USD billion) Forecast, by End-user, 2021-2034

Table 60:  Middle East & Africa Cancer Profiling Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034

Table 61:  GCC Cancer Profiling Market Revenue (USD billion) Forecast, by Cancer Type, 2021-2034

Table 62:  South Africa Cancer Profiling Market Revenue (USD billion) Forecast, by Cancer Type, 2021-2034

Table 63:  Rest of Middle East and Africa Cancer Profiling Market Revenue (USD billion) Forecast, by Cancer Type, 2021-2034

Cancer Profiling Market
  • 2021-2034
  • 2025
  • 2021-2024
  • 250
Download Free Sample

    man icon
    Mail icon
    Captcha refresh

Get 20% Free Customization

Expand Regional and Country Coverage, Segments Analysis, Company Profiles, Competitive Benchmarking, and End-user Insights.

Get 20% Free Customization On This Report
Growth Advisory Services
    How can we help you uncover new opportunities and scale faster?
Clients
3M
Toshiba
Fresenius
Johnson
Siemens
Abbot
Allergan
American Medical Association
Becton, Dickinson and Company
Bristol-Myers Squibb Company
Henry Schein
Mckesson
Mindray
National Institutes of Health (NIH)
Nihon Kohden
Olympus
Quest Diagnostics
Sanofi
Smith & Nephew
Straumann

Related Reports